Skip to content

Author

C. Ren

We have 2 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Targeting GEM Reprograms Macrophages and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.

GTP-binding protein overexpressed in skeletal muscle (GEM) is identified as a tumor cell-intrinsic regulator associated with poor response to anti-PD-L1 therapy in ESCC and a GEM-SERPINE1-LRP1 signaling axis that drives macrophage-mediated immune suppression is defined.

Lin-Feng Wu, C. Ren, Yi-Fei Zhang et al. · 0 citations
Aug 2026

AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies

It is reported that primary HER2-specific targeted therapy (tucatinib) resistant or sensitive breast cancers derived from clinical trial patients exhibited differential protein profiles and was proposed as a promising therapeutic strategy for HER2-positive breast cancer.

Qing Guo, Xinyu Chen, Lin-Feng Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.